10-Q: Blum Holdings Faces Going Concern Doubt Amidst Losses

Blum Holdings, Inc. reports continued net losses and a worsening working capital deficit, raising substantial doubt about its ability to continue as a going concern, despite revenue growth and strategic acquisitions.

Summary

• Blum Holdings, Inc. reported a net loss from continuing operations of $5.01 million for the nine months ended September 30, 2025, compared to a net income of $0.14 million for the same period in 2024.
• Total revenue increased by 6.4% to $10.57 million for the nine months ended September 30, 2025, from $9.93 million in the prior year.
• Selling, General & Administrative (SG&A) expenses significantly decreased by 40.6% to $8.81 million for the nine months ended September 30, 2025, from $14.84 million in 2024, primarily due to reduced professional fees and lower operating costs from divested dispensaries.
• The company's cash balance decreased to $0.39 million as of September 30, 2025, from $1.04 million at December 31, 2024.
• The working capital deficit worsened to $23.7 million as of September 30, 2025, compared to $6.79 million at December 31, 2024.
• Blum Holdings operates five cannabis retail locations in California as of September 30, 2025, following the acquisition of EWCR (Santa Clara County) in May 2025 and Green Door Redding, LLC (GDR) in July 2025.
• The company's subsidiaries, Unrivaled Brands, Inc. and Halladay Holding, LLC, filed for Chapter 11 bankruptcy in November 2024, with a settlement reached with People's California, LLC in May 2025.
• Management expects to experience further net losses in 2025 and the foreseeable future, and there is substantial doubt about the company's ability to continue as a going concern for the next twelve months.
• Material weaknesses in internal control over financial reporting were identified, including failure to timely record transactions and ineffective user access controls.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, evidenced by significant net losses, a worsening working capital deficit, and an explicit 'going concern' warning. While revenue increased and operating expenses were reduced, these positives are overshadowed by critical liquidity issues, reliance on future capital raises, and material weaknesses in internal controls. The unpaid promissory notes further highlight financial instability.

Positives

• Revenue from continuing operations increased by 6.4% to $10.57 million for the nine months ended September 30, 2025, driven by new retail dispensaries.
• Selling, General & Administrative expenses decreased significantly by 40.6% ($6.03 million) for the nine months ended September 30, 2025, reflecting operational restructuring and cost reduction efforts.
• Loss from operations improved by 70.4% ($8.6 million) for the nine months ended September 30, 2025, compared to the prior year.
• The company expanded its retail footprint by adding two new dispensaries in Santa Clara County (EWCR) and Redding (Cookies Redding) in May and July 2025, respectively.
• A significant pre-petition litigation with People's California, LLC was settled and approved by the Bankruptcy Court in May 2025, resolving a major legal dispute.
• Management is focused on a 'flywheel platform company' model to scale through direct ownership and operational control agreements, emphasizing capital efficiency and brand strength.

Negatives

• The company incurred a net loss from continuing operations of $5.01 million for the nine months ended September 30, 2025, and $2.56 million for the three months ended September 30, 2025.
• An accumulated deficit of $426.09 million as of September 30, 2025, indicates significant historical losses.
• Cash and cash equivalents decreased to $0.39 million as of September 30, 2025, from $1.04 million at December 31, 2024.
• The working capital deficit worsened to $23.7 million as of September 30, 2025, from $6.79 million at December 31, 2024, with current assets at only 0.07 times current liabilities.
• Substantial doubt exists regarding the company's ability to continue as a going concern for the next twelve months due to insufficient liquidity and expected future net losses.
• Unsecured promissory notes totaling $0.53 million (dated February 25, 2025, and April 18, 2025) were unpaid as of September 30, 2025, and management is renegotiating terms.
• Total liabilities increased significantly to $52.35 million as of September 30, 2025, from $29.56 million at December 31, 2024, largely due to acquisitions.
• Income tax expense increased to $1.04 million for the nine months ended September 30, 2025, despite net losses, primarily due to IRC Section 280E limitations on cannabis businesses.
• Gross margin for ongoing retail operations slightly declined from 50.8% to 49.5% for the nine months ended September 30, 2025, reflecting the impact of a value-oriented pricing model from a recent acquisition.

Risks

• Substantial doubt about the ability to continue as a going concern due to recurring losses, negative cash flows from operations, and a significant working capital deficit.
• Inability to generate sufficient cash from operating activities to fund ongoing operations, requiring additional funds through financing.
• No guarantee that additional capital will be available on acceptable terms, on an acceptable schedule, or at all, leading to potential scaling down or cessation of operations.
• Issuance of additional securities may result in significant dilution to current stockholders.
• Material weaknesses in internal control over financial reporting, including failure to timely record transactions and ineffective user access controls, could lead to financial misstatements.
• Ongoing litigation and claims arising in the ordinary course of business, despite some settlements, pose potential financial liabilities.
• Dependence on licensed vendors in California for cannabis products, with potential impact on sales if relationships with sufficient licensed vendors cannot be maintained.
• Exposure to the limitations of U.S. Internal Revenue Code Section 280E, which restricts expense deductions for cannabis operations, resulting in higher effective tax rates.

Future Outlook

Management intends to maintain a balanced approach to growth by strengthening cash flow, maintaining a conservative balance sheet, and funding core drivers such as inventory, targeted promotions, and selective acquisitions. They anticipate improvements in cash flow from operating activities as the growth strategy is executed and expect SG&A to remain well managed relative to revenue, supporting improved operating leverage. The company continues to seek financing structures that align with its long-term goals, focusing on flexibility and capital efficiency.

Management Comments

• "Management expects to experience further net losses in 2025 and in the foreseeable future."
• "The Company's future success is dependent upon its ability to achieve profitable operations and generate cash from operating activities."
• "There is no guarantee that the Company will be able to generate enough revenue or raise capital to support its operations."
• "The risks and uncertainties surrounding the ability to raise capital, the limited capital resources, and the weak industry conditions impacting the Company's business raise substantial doubt as to its ability to continue as a going concern for twelve months from the issuance of these financial statements."
• "Blum is progressing from a period of restructuring and cost reduction into a more focused and disciplined growth phase."
• "Management believes this work is beginning to show results, as Blum continues to add profitable retail locations in key California markets and expand its reach through a mix of acquisitions, management agreements, and partnerships that allow for growth without significant cash commitments."
• "Blum's strategy centers on disciplined execution, prioritizing profitability, operational efficiency, and sustainable value creation for shareholders."

Industry Context

The company operates in the highly regulated California cannabis market, which presents both opportunities for growth through retail expansion and challenges due to regulatory complexities like IRC Section 280E, limiting deductible expenses. The strategic pivot to a 'platform model' with a focus on capital efficiency and operational leverage suggests an adaptation to the competitive and capital-intensive nature of the cannabis industry. The acquisition of additional retail dispensaries indicates a continued belief in the growth potential of the California retail segment, despite broader industry headwinds and the company's own financial struggles.

Comparison to Industry Standards

• The company's gross margin for ongoing retail operations declined slightly from 50.8% to 49.5% for the nine months ended September 30, 2025. This is attributed to the acquisition of EWCR, which operates with lower margins under a value-oriented pricing model. This suggests a strategic trade-off between margin and sales volume, which is a common competitive dynamic in the cannabis retail sector, where companies like Curaleaf or Green Thumb Industries might also employ diverse pricing strategies across their portfolios.
• The significant accumulated deficit of $426.09 million and the going concern warning indicate a financial position considerably weaker than established, profitable cannabis multi-state operators (MSOs) such as Trulieve Cannabis Corp. or Cresco Labs, which typically demonstrate stronger balance sheets and positive operating cash flows.
• The company's reliance on non-cash consideration, earn-outs, and management agreements for expansion aligns with capital-efficient growth strategies seen in smaller or emerging cannabis companies, which may lack the robust access to traditional capital markets enjoyed by larger, more mature players.

Management Changes

Corporate Governance

Legal Proceedings

• Unrivaled Brands, Inc. and Halladay Holding, LLC filed for Chapter 11 bankruptcy on November 6, 2024, following insolvency and litigation by People's California, LLC.
• A global settlement was reached with People's California, LLC on February 12, 2025, with definitive documentation executed on March 27, 2025, and court approval on May 2, 2025. The settlement dismissed all pre-petition litigation and bankruptcy adversary proceedings between the parties.
• One contested matter remains in the bankruptcy cases regarding whether Unrivaled Brands, Inc. should be allowed to abandon its equity shares in Mystic Holdings, LLC, with a hearing continued to December 3, 2025.
• Ongoing litigation includes 1149 South LA Street Fashion District, LLC v. Unrivaled Brands, Inc. (breach of contract, $0.58 million in damages claimed, litigation stayed by bankruptcy).
• Greenlane Holdings, LLC v. Unrivaled Brands, Inc. (breach of contract, judgment of $1.85 million against the company, Greenlane is now an unsecured creditor in bankruptcy).
• WGS Group, Inc. v. Unrivaled Brands, Inc. (claims for damages and declaratory relief, litigation stayed by bankruptcy, WGS Group and Gateway Acceptance Company are unsecured creditors).
• No Smoking Allowed Except Turn, LLC v. Peoples Riverside, LLC and Unrivaled Brands, Inc. (breach of contract and negligence, damages exceeding $0.60 million claimed, litigation stayed by bankruptcy).
• Glaser Weil Fink Howard Jordan & Shapiro LLP v. Unrivaled Brands, Inc. (breach of contract, $0.28 million in damages claimed, litigation stayed by bankruptcy).
• Fusion LLF, LLC v. Unrivaled Brands, Inc. (breach of contract, $4.55 million in damages claimed, litigation stayed by bankruptcy).
• Fairway Medical Plaza, LLC v. Unrivaled Brands, Inc., et al (breach of contract, intentional interference, negligence, litigation stayed by bankruptcy).

Related Party Transactions

• Engagement fees totaling $0.23 million for the three months and $0.69 million for the nine months ended September 30, 2025, were incurred with Adnant, LLC for executive level consulting services. The monthly service fee was decreased from $0.25 million to $0.08 million effective January 1, 2025.
• Total amounts due to Adnant, LLC were $2.04 million as of September 30, 2025, and $1.18 million as of December 31, 2024, included in 'Related Party Accounts Payable'.
• Rent expense of $27,968 for the three months and $0.11 million for the nine months ended September 30, 2025, was incurred with Adnant, LLC for a sublease agreement for the corporate headquarters.
• On November 13, 2025, the company issued 1,530,612 shares of Common Stock to Adnant, LLC as repayment of accounts payable totaling $1.50 million.
• On November 13, 2025, the company issued an additional 2,482,308 shares of Common Stock to Adnant, LLC pursuant to a Debt Conversion Agreement.
• Sabas Carrillo (CEO), Patty Chan (CFO), James Miller (former COO), and Robert Baca (Chief Legal Officer) were investors in the 2023 Private Placement of Series V Preferred Stock.

Stakeholder Impact

• Shareholders face significant dilution risk from ongoing and future capital raises, including the issuance of common stock to related parties and for acquisitions. The substantial doubt about the company's going concern status poses a severe risk to investment value.
• Employees (133 as of September 30, 2025) may experience uncertainty due to the company's financial instability and ongoing operational restructuring, although management aims for a leaner corporate structure.
• Customers in California's cannabis market may benefit from the company's expanded retail footprint and focus on brand strength and customer experience, but the company's financial health could impact service continuity.
• Suppliers and creditors face elevated risk, as evidenced by unpaid promissory notes and the bankruptcy proceedings of subsidiaries. The company's ability to meet its obligations is under severe strain.
• Regulatory bodies will continue to monitor the company's compliance, especially given the material weaknesses in internal controls and the complexities of cannabis industry regulations.

Next Steps

• Management plans to continue evaluating options to further reduce cash requirements and raise additional funds, including obtaining loans and selling common stock.
• The company intends to enhance its internal control over financial reporting to remediate identified material weaknesses, with expected remediation during fiscal year 2025.
• Negotiations are ongoing for the terms of several promissory notes that have received advance payments or are currently unpaid.
• The company intends to negotiate and enter into definitive agreements for the acquisitions of Mt. Tam Ventures II, LLC, Mesh Ventures, LLC, and a holding company with an equity interest in Cookies Creative Consulting & Promotions, Inc.

Key Dates

Recommendation

Blum Holdings, Inc. presents an extremely high-risk investment profile. The explicit 'going concern' warning, coupled with a rapidly deteriorating cash position ($0.39 million) and a widening working capital deficit ($23.7 million), indicates severe financial distress and an inability to meet short-term obligations. While revenue growth and reduced SG&A are noted, they are insufficient to offset persistent net losses and a massive accumulated deficit. The reliance on continuous capital raises, with no guarantee of success or favorable terms, and the identified material weaknesses in internal controls further compound the risk. The company's future is highly uncertain, making it an unsuitable investment for all but the most speculative investors willing to risk total loss of capital.

Keywords

Cannabis, Retail, Distribution, California, SEC Filing, 10-Q, Quarterly Report, Financial Results, Going Concern, Liquidity, Acquisitions, Corporate Governance, Risk Factors, Promissory Notes, Warrants, Mezzanine Equity, Stockholders Deficit, Operational Restructuring, Korova, Cookies Sacramento, Cookies Redding